Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices – ET HealthWorld
London: Medtech firm Zimmer Biomet Holdings beat Wall Street estimates for first-quarter profit on Thursday, on the back of robust demand for its devices that are used in knee and hip reconstruction procedures. Zimmer’s results extend a strong quarter for medical device makers, including peer Stryker Corp which raised its annual profit outlook betting on … Read more